Last reviewed · How we verify

NCT03852095

Single Time Management Diseases in Pediatric Traumatology

Completed Last updated 19 July 2019
What this trial tests

trial testing minor trauma in Fractures, Bone in 150 participants. Completed in 28 June 2019.

Timeline
2 November 2018
Primary endpoint
14 June 2019
28 June 2019

Quick facts

Lead sponsorFondation Lenval
StatusCompleted
Study typeOBSERVATIONAL
Enrollment150
Start date2 November 2018
Primary completion14 June 2019
Estimated completion28 June 2019
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Fondation Lenval — full company profile →

Who can join

Adults 1 to 18, any sex, with Fractures, Bone. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A recent internal study evaluating the relevance of the visit to traumatology consultation in our establishment highlight that 49.3% of consultations were not relevant passages. The project consists of individualizing 5 to 6 pathologies and to create care sheets and patient sheets to be given to the care teams and patients when the pathology lends itself to it. The aim is to reduce the irrelevant passage rate during these consultations, which is the source of absence from iterative work for parents, collateral expenses (toll, parking), absence from school for the children, unjustified expenses and X-ray examination unnecessary most often.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fractures, Bone

Currently open trials in the same condition.

Other Fondation Lenval trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03852095.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing